Research Topics

Populations

EPAR TECHNICAL REPORT #362
Publication Date: 01/16/2019
Type: Data Analysis
Abstract

Self-Help Groups (SHGs) in Sub-Saharan Africa can be defined as mutual assistance organizations through which individuals undertake collective action in order to improve their own lives. “Collective action” implies that individuals share their time, labor, money, or other assets with the group. In a recent EPAR data analysis, we use three nationally-representative survey tools to examine various indicators related to the coverage and prevalence of Self-Help Group usage across six Sub-Saharan African countries. EPAR has developed Stata .do files for the construction of a set of self-help group indicators using data from the Living Standards Measurement Study - Integrated Surveys on Agriculture (LSMS-ISA), Financial Inclusion Index (FII), and FinScope.

We compiled a set of summary statistics for the final indicators using data from the following survey instruments:

  • Ethiopia:
    • Ethiopia Socioeconomic Survey (ESS), Wave 3 (2015-16)
  • Kenya:
    • Kenya FinScope, Wave 4 (2015)
    • Kenya FII, Wave 4 (2016)
  • Nigeria
    • Nigeria FII, Wave 4 (2016)
  • Rwanda:
    • Rwanda FII, Wave 4 (2016)
  • Tanzania:
    • Tanzania National Panel Survey (TNPS), Wave 4 (2014-15)
    • Tanzania FinScope, Wave 4 (2017)
    • Tanzania FII, Wave 4 (2016)
  • Uganda:
    • Uganda FinScope, Wave 3 (2013)
    • Uganda FII, Wave 4 (2016)

The raw survey data files are available for download free of charge from the World Bank LSMS-ISA website, the Financial Sector Deepening Trust website, and the Financial Inclusion Insights website. The .do files process the data and create final data sets at the household (LSMS-ISA) and individual (FII, FinScope) levels with labeled variables, which can be used to estimate summary statistics for the indicators.

All the instruments include nationally-representative samples. All estimates from the LSMS-ISA are household-level cluster-weighted means, while all estimates from FII and FinScope are calculated as individual-level weighted means. The proportions in the Indicators Spreadsheet are therefore estimates of the true proportion of individuals/households in the national population during the year of the survey. EPAR also created a Tableau visualization of these summary statistics, which can be found here.

We have also prepared a document outlining the construction decisions for each indicator across survey instruments and countries. We attempted to follow the same construction approach across instruments, and note any situations where differences in the instruments made this impossible.

The spreadsheet includes estimates of the following indicators created in our code files:

Sub-Populations

  • Proportion of individuals who have access to a mobile phone
  • Proportion of individuals who have official identification
  • Proportion of individuals who are female
  • Proportion of individuals who use mobile money
  • Proportion of individuals who have a bank account
  • Proportion of individuals who live in a rural area
  • Individual Poverty Status
    • Two Lowest PPI Quintiles
    • Middle PPI Quintile
    • Two Highest PPI Quintiles

Coverage & Prevalence

  • Proportion of individuals who have interacted with a SHG
  • Proportion of individuals who have used an SHG for financial services
  • Proportion of individuals who depend most on SHGs for financial advice
  • Proportion of individuals who have received financial advice from a SHG
  • Proportion of households that have interacted with a SHG
  • Proportion of households in communities with at least one SHG
  • Proportion of households in communities with access to multiple farmer cooperative groups
  • Proportion of households who have used an SHG for financial services

Characteristics
In addition, we produced estimates for 29 indicators related to characteristics of SHG use including indicators related to frequency of SHG use, characteristics of SHG groups, and individual/household trust of SHGs.

EPAR Technical Report #345
Publication Date: 12/01/2017
Type: Literature Review
Abstract

The share of private sector funding, relative to public sector funding, for drug, vaccine, and diagnostic research & development (R&D) differs considerably across diseases. Private sector investment in overall health R&D exceeds $150 billion annually, but is largely concentrated on non-communicable chronic diseases with only an estimated $5.9 billion focused on "global health", targeting diseases that primarily affect low and middle-income countries (LMICs). We examine the evidence for five specific disincentives to private sector global health R&D investment: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed and sunk costs, and downstream rents from imperfect markets. Though all five may affect estimates of net returns from an investment decision, they are worth examining separately as each calls for a different intervention or remediation to change behavior.

EPAR Technical Report #359
Publication Date: 11/13/2017
Type: Literature Review
Abstract

Cash transfer programs are interventions that directly provide cash to target specific populations with the aim of reducing poverty and supporting a variety of development outcomes. Low- and middle-income countries have increasingly adopted cash transfer programs as central elements of their poverty reduction and social protection strategies. Bastagli et al. (2016) report that around 130 low- and middle-income countries have at least one UCT program, and 63 countries have at least one CCT program (up from 27 countries in 2008). Through a comprehensive review of literature, this report primarily considers the evidence of the long-term impacts of cash transfer programs in low- and lower middle-income countries. A review of 54 reviews that aggregate and summarize findings from multiple studies of cash transfer programs reveals largely positive evidence on long-term outcomes related to general health, reproductive health, nutrition, labor markets, poverty, and gender and intra-household dynamics, though findings vary by context and in many cases overall conclusions on the long-term impacts of cash transfers are mixed. In addition, evidence on long-term impacts for many outcome measures is limited, and few studies explicitly aim to measure long-term impacts distinctly from immediate or short-term impacts of cash transfers.

EPAR Technical Report #338
Publication Date: 05/19/2017
Type: Literature Review
Abstract

The concept of global public goods represents a framework for organizing and financing international cooperation in global health research and development (R&D). Advances in scientific and clinical knowledge produced by biomedical R&D can be considered public goods insofar as they can be used repeatedly (non-rival consumption) and it is difficult or costly to exclude non-payers from gaining access (non-excludable). This paper considers the public good characteristics of biomedical R&D in global health and describes the theoretical and observed factors in the allocation R&D funding by public, private, and philanthropic sources.

EPAR Technical Report #130
Publication Date: 01/29/2011
Type: Literature Review
Abstract

The purpose of this literature review is to provide qualitative and quantitative examples of technologies, constraints and incentives for efficient waste treatment and reuse in Sub-Saharan Africa and Southeast Asia.  We present relevant case studies and expert observations and experiences on the nutrient content in urine and feces, contaminants frequently found in untreated sludge and wastewater, waste treatment technologies that may be relevant for low-income countries, risks associated with waste reuse, benefits to resource recovery in agriculture. We further discuss reasons for waste treatment failures, including urbanization, observations on challenges with market-driven reuse in less developed countries, and examples of net-positive energy facilities in Europe and the United States. Much of the evidence presented in the literature relates to wastewater treatment processes or the sludge produced from wastewater treatment as opposed to untreated fecal sludge.  However, examples of risks, failures, and opportunities for raw sludge treatment and reuse are discussed when available.  In some cases, empirical evidence or case studies were not available for developing countries and alternatives are presented.  Overall we found the empirical evidence on waste treatment and reuse in developing countries is quite thin.